FDA approves Gilead’s twice-yearly HIV prevention injection, offering a powerful and convenient new option

FDA approves Gilead’s twice-yearly HIV prevention injection, offering a powerful and convenient new option

The Food and Drug Administration on Wednesday approved Gilead’s twice-yearly antiviral injection for preventing HIV – a milestone that the company and some experts say could help bring the world closer to ending the decades-long epidemic caused by the virus.  But the launch of the injectable drug, which will be marketed under the name Yeztugo, … Read more